Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
18.68
Price to sales ratio
5.03
Dividends per share
2.4
Dividend yield %
1.23

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
316
BDX
Becton, Dickinson and Company Common Stock
188.13 USD-1.13%-0.07%+13.41%-1.56%51.24 B USD
416
ALC
Alcon Inc. Ordinary Shares
72.23 USD-0.66%-0.82%+4.64%-9.14%35.21 B USD
533
WST
West Pharmaceutical Services, Inc. Common Stock
346.13 USD-1.11%-3.28%+2.35%+15.03%24.36 B USD
695
SOLV
Solventum Corporation Common Stock
90.90 USD-0.74%+3.04%+5.85%+24.55%15.47 B USD

Frequently asked questions about ResMed Inc.

What is the ResMed Inc. stock price today?

The current price of ResMed Inc. (RMD) is 235.76. Over the past 24 hours, the stock has changed by +0.02%. Follow the RMD chart for real-time price dynamics.

What is the stock ticker of ResMed Inc.?

ResMed Inc. trades under the ticker RMD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is ResMed Inc. stock going up?

RMD has changed by +2.85% over the last week, +13.43% over the last month, and -8.97% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of ResMed Inc.?

ResMed Inc. currently has a market capitalization of 34.01 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does ResMed Inc. release financial reports?

Yes. You can track ResMed Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were ResMed Inc. earnings last quarter?

Last quarter, ResMed Inc. reported earnings of 2.66 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was ResMed Inc. revenue for the last quarter?

ResMed Inc. reported quarterly revenue of 1.46 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was ResMed Inc. net income for the last quarter?

ResMed Inc. reported net income of 383.43 M for the last quarter. The previous quarter showed 398.73 M, which means net income changed by -3.84%.

Does ResMed Inc. pay dividends?

ResMed Inc. paid a dividend per share of 2.4. The current dividend yield is 1.23%. Dividend data can help income-focused investors evaluate the stock.

Is ResMed Inc. a good dividend stock?

ResMed Inc. currently has a dividend yield of 1.23%. Previously, the dividend yield was 1.75%, compared with 1.6% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.

How many employees does ResMed Inc. have?

As of the latest available data, ResMed Inc. has 10.6 K employees. Workforce size can provide additional context about the company's scale and operations.

What is ResMed Inc. EBITDA?

ResMed Inc. EBITDA is 493.49 M, and its EBITDA margin is 33.72%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy ResMed Inc. stock?

You can buy ResMed Inc. (RMD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in ResMed Inc. stock?

Investing in ResMed Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RMD chart and related analysis on metatrader.com as part of your research.

ResMed Inc. Common Stock

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.

News